Real Money

How Many Days to Turn a Penny into a Million Dollars?

2009-12-05T14:32:00.000-05:00

Lets assume you have a penny (once cent).

Lets say you invested the penny and at the end of the first day it doubled. You would then have two cents. Nothing to get excited about right?

Lets assume you started investing day after day. So on day two you invested your two cents and ended the day with 4 cents. Each succeeding day you invested and every day you doubled your money.

How many days would it take before you had $1,000,000 (one million dollars)?

If you don't know the answer to this question off the top of your head, you might be surprised when you learn the answer.

Subscribe to The Alzheimer's Reading Room--via Email

Answer: 28 days.

Popular articles on the Alzheimer's Reading Room
Worried About Alzheimer's Disease
Dementia and the Eight Types of Dementia
H1N1 Flu Virus Everything You Need to Know
Does the Combination of Aricept and Namenda Help Slow the Rate of Decline in Alzheimer's Patients
Test Your Memory (TYM) for Alzheimer's or Dementia in Five Minutes
Dimebon Connection Study
The Metamorphosis of This Alzheimer's Caregiver (Part One)
The Mini-Cog Test for Alzheimer's and Dementia
Worried about Alzheimer's? Five Ways to Protect Yourself
Is it Really Alzheimer's or Something Else?
Alzheimer's Wandering Why it Happens and What to Do
50 Good Reasons to Subscribe to the Alzheimer's Reading Room Now
World Health Care Spending and Performance Ranking by Country (Table)
Urinary Incontinence -- How We Beat Alzheimer's Incontinence
Are Alzheimer's Caregivers the Forgotten?
A Simple Three Minute Test Can Detect the Earliest Stage of Alzheimer's Disease
Wii a Useful Tool for Alzheimer's Caregivers
2009 Alzheimer's Disease Facts and Figures

Bob DeMarco is the editor of the Alzheimer's Reading Room and an Alzheimer's caregiver. The Alzheimer's Reading Room is the number one website on the Internet for news, advice, and insight into Alzheimer's disease. Bob has written more than 950 articles with more than 8,000 links on the Internet. Bob resides in Delray Beach, FL.

Original content Bob DeMarco, Alzheimer's Reading Room

Treasury Announces Additional Tax Deductions for New Auto Purchases

2009-06-11T11:40:00.000-04:00

The Department of Treasury today announced that a tax deduction for the purchase of new motor vehicles is available in states that do not have a state sales tax.

Under the American Recovery and Reinvestment Act of 2009, taxpayers who buy a new motor vehicle this year are entitled to deduct state or local sales or excise taxes paid on the purchase.

The Treasury Department has determined that purchases made in states without a sales tax–such as Alaska, Delaware, Hawaii, Montana, New Hampshire and Oregon–can also qualify for the deduction.

"Building on the Recovery Act, the Treasury Department is taking steps to make sure every American, in every state qualifies for a tax deduction when purchasing a new car," said Deputy Secretary Neal Wolin. "This tax deduction not only increases support for the auto industry as it seeks to rebuild, but also puts money back into the pockets of hardworking Americans."

Taxpayers who purchase a new motor vehicle in states that do not impose state sales or excise taxes are entitled to deduct other fees or taxes imposed by the state or local government that are based on the vehicle's sales price or as a per unit fee. According to the IRS and Treasury, the intent of the provision is that these other fees or taxes could qualify for purposes of the special tax deduction.

To qualify for the deduction, the vehicle must be purchased after Feb. 16, 2009, and before Jan. 1, 2010. The special deduction is available regardless of whether taxpayers itemize deductions on their returns. Taxpayers can claim this special deduction only on their 2009 tax returns next year.

The deduction is limited to the fees or taxes paid on up to $49,500 of the purchase price of a qualified new car, light truck, motor home, or motorcycle.

The amount of the deduction is phased out for taxpayers whose modified adjusted gross income is between $125,000 and $135,000 for individual filers and between $250,000 and $260,000 for joint filers.

Subscribe to Smart Clips via Email

The Housing and Credit Crisis Explained

2009-06-11T09:54:00.001-04:00

This presentation on the Housing and Credit crisis is the best I have seen. It explains everything from soup to nuts.

Each slide contains a graph that is well explained.

They say a picture is worth a thousand words.

Once you get through this, you will understanding the current credit crisis in housing, and what to expect in the years ahead.

If you take the time to view and read this you will be fully informed.

Hit the full screen button in the upper right hand corner of the panel below.

T2 Partners Presentation on the Mortgage Crisis

Publish at Scribd or explore others: Research Business & Economics Finance Non-fiction world culture

Subscribe to All American Investor via Email

Bob DeMarco is a citizen journalist and twenty year Wall Street veteran. Bob has written more than 500 articles with more than 11,000 links to his work on the Internet. Content from All American Investor has been syndicated on Reuters, the Wall Street Journal, Fox News, Pluck, Blog Critics, and a growing list of newspaper websites. Bob is actively seeking syndication and writing assignments.

More from All American Investor

Bond Vigilantes Take over in the Long End (Graph)
Ten Year Treasury Yield in Orbit (Graph)
Ten Year Interest Rates Rising (Chart)
Option ARM--The Toxic Mortgage
Systemic Risk Defined--Too Big to Fail
Ray Dalio on the current state of affairs in the market
Roubini Predicts U.S. Losses May Reach $3.6 Trillion
60 Minutes -- Cold Fusion

Kindle: Amazon's 6" Wireless Reading Device

Follow All American Investor on Twitter

TauRx Therapeutics-- New treatment halts progress of Alzheimer's disease

2008-08-09T12:22:00.000-04:00

clipped from alzheimersreadingroom.blogspot.com

The results of the Phase 2 study of TauRx's new treatment strongly suggest that it is possible to halt progression in mild and moderate Alzheimer's. TauRx is continuing to refine its treatment and hopes that restoration may be possible at least at the earlier stages with improved versions of its drug. Tangles are already destroying nerve cells in parts of the brain critical for memory in people in their fifties and upwards. The ultimate goal is to develop a product that is convenient for patients that could be widely used at the very earliest stages of the disease, long before patients experience the first symptoms of Alzheimer's.

Amazon.com Widgets

CNBC Million Dollar Portfolio Bonus Bucks Answers

2008-05-21T12:44:00.000-04:00

Squawk Box
According to Boone Pickens, how much is the U.S. sending overseas for oil?
Answer: 4x the Iraq War’s cost

Squawk on the Street
On Tuesday, Jim Cramer said it was “time to ring the register” and sell. But what railroad stock was he BULLISH on? Answer: CSX

The Call
Short seller Doug Kass mentioned Warren Buffett and a famous tyrant in a CNBC interview. Which tyrant?
Answer: Napoleon Bonaparte

Power Lunch
Which “gloom & doom” figure told CNBC Monday “I think the economy really stinks”? Answer: Marc Faber

Get Notification of the CNBC Bonus Bucks Trivia answers every day at E F Hutton

Robert T DeMarco Weblog: The latest in Financial Infotainment--Minyanville

2007-07-19T12:55:00.000-04:00

Robert T DeMarco Weblog: The latest in Financial Infotainment--Minyanville
A friend of mine sent me a link to this website, Minyanville. The site is will worth visiting. Informative and entertaining. The stuff on China, subprime loans and trading is thought provoking. Chances are good you will be sending this link along to your freinds.

Some examples of the headline stories.

Fire in the Hole!
Todd Harrison
...as yesterday’s false alarm once again proved, structural smoke won’t matter until someone actually sees a fire.

Testing the Waters of Intel
Jeff Macke
Plucking at the strings of lunacy, trying to find something valid enough to trade off, thus becomes a somewhat futile exercise...

Stocks To Watch: Dell, eBay, Ford, IBM, Sysco
Minyanville Staff
Today's top stories and some stocks with potential to move...

Bear Stearns' Hedge Fund Mess
Bennet Sedacca
Brokerage paper has been widening relative to Treasuries of late, but so has everything else, as perhaps it should.

The Market's Remarkable Symmetry
The market may have an agenda higher in terms of time and price, but... there are many clusters of time, price and pattern projecting a turning point in this neighborhood.

Subscribe to Robert T DeMarco Weblog by Email

hedge funds, infotainment, investing, minyanville, subprime loans, trading

Case-Shiller Home Price Index

2007-05-11T11:09:00.000-04:00

CNBC Portfolio Challenge Bonus Bucks Answers for Friday, May 11, 2007 and CNBC Million Dollar Portfolio Challenge

Case-Shiller Home Price Index

Get the Answers

Case-Shiller Home Price Index

According to the S&P/Case-Shiller Home Price Index, home prices in Seattle are up how much from a year ago?

According to the S&P/Case-Shiller Home Price Index, home prices in Seattle are up how much from a year ago?

More blogs about href="http://technorati.com/blogs/According+to+the+S%26P%2FCase-Shiller+Home+Price+Index%2C+home+prices+in+Seattle+are+up+how+much+from+a+year+ago%3F" rel="tag directory">According to the S&P/Case-Shiller Home Price Index, home prices in Seattle are up how much from a year ago?.
href="http://technorati.com/blogs/">

CNBC Portfolio Challenge Bonus Bucks Answers

2007-04-20T10:53:00.000-04:00

CNBC Portfolio Challenge Bonus Bucks Answers for Friday, April 20, 2007 and CNBC Million Dollar Portfolio Challenge

Google reported that it's quaterly net profit rose how much?

Shareholders of Firstgroup will meet today to close a 1.8B pound takeover deal of what major U.S. services company?

Get the Answers

Robert T DeMarco Weblog: CNBC Portfolio Challenge Bonus Bucks Answers

2007-04-18T11:40:00.000-04:00

CNBC Portfolio Challenge Bonus Bucks Answers for Wednesday, April 18, 2007 and CNBC Million Dollar Portfolio Challenge

According to the Mortgage Bankers Association, borrowing costs on 30-year fixed-rate mortgages averaged how much last week?

The European Patent Forum kicks off today in which major European city?

Get the Answers

CNBC Million Dollar Portfolio Challenge

2007-04-09T10:47:00.000-04:00

CNBC Portfolio Challenge Bonus Bucks Answers for Monday, April 9, 2007 and CNBC Million Dollar Portfolio Challenge

The largest U.S union federation, AFL-CIO, is targeting which company in a campaign against executive pay?

Citigroup purchased Taiwan's Bank of Overseas Chinese in its third Asian purchase in recent months. How much did they pay?

Get the Answers

CNBC Million Dollar Portfolio Challenge

2007-03-30T12:48:00.000-04:00

CNBC Portfolio Challenge Bonus Bucks Answers for Friday, March 30, 2007 and CNBC Million Dollar Portfolio Challenge

How many new stores did Home Depot open in the U.S. in 2006?
The FDA-approved drug Provenge is used to fight what disease?

Get the Answers

CNBC Million Dollar Portfolio Challenge

2007-03-19T10:11:00.000-04:00

All American Investor: CNBC Million Dollar Portfolio Challenge

Robert T DeMarco Weblog: Ethanol inflames grain market

2007-01-15T16:30:00.000-05:00

Robert T DeMarco Weblog: Ethanol inflames grain market

The CareGiver: Huperzine A Factsheet (Alzheimer's)

2006-11-18T15:55:00.000-05:00

The CareGiver: Huperzine A Factsheet (Alzheimer's)

I recently read about Huperzine A. The following page contains a fact sheet about the herb. Huperzine A may have cognition-enhancing activity in some.

Source Huperzine A

TRADE NAMES

Huperzine A is available from numerous manufacturers generically. Branded products include Memorall (PharmAssure), Huperzine Rx-Brain (Nature's Plus).

DESCRIPTION

Huperzine A is a plant alkaloid derived from the Chinese club moss plant, Huperzia serrata, which is a member of the Lycopodium species. Huperzia serrata has been used in Chinese folk medicine for the treatment of fevers and inflammation.

Huperzine A has been found to have acetylcholinesterase activity. Huperzine B, also derived from Huperzia serrata, is a much less potent acetylcholinesterase inhibitor. Natural huperzine A is a chiral molecule also called L-huperzine A or (-)-huperzine A. Synthetic huperzine A is a racemic mixture called (±)-huperzine A. Huperzine A is also known as HUP, hup A and selagine. In Chinese medicine, the extract of Huperzia serrata is known as Chien Tseng Ta and shuangyiping. Huperzine A derivatives are being developed for pharmaceutical application.

ACTIONS AND PHARMACOLOGY ACTIONS

Huperzine A may have cognition-enhancing activity in some.

MECHANISM OF ACTION

Alzheimer's disease is a neurodegenerative disorder associated with neuritic plaques that affect the cerebral cortex, amygdala and hippocampus. There is also neurotransmission damage in the brain. One of the major functional deficits in Alzheimer's disease is a hypofunction of cholinergic neurons. This leads to the cholinergic hypothesis of Alzheimer's disease and the rationale for strategies to increase acetylcholine in the brains of Alzheimer's disease patients. Two FDA-approved drugs for the treatment of Alzheimer's disease, tacrine and donepezil, are acetylcholinesterase inhibitors.

Huperzine A is also an acetylcholinesterase inhibitor and has been found to increase acetylcholine levels in the rat brain following its administration. It also increases norepinephrine and dopamine, but not serotonin levels. The natural L or (-)-huperzine A is approximately three times more potent than the racemic or (±)-huperzine A in vitro.

PHARMACOKINETICS

There are limited pharmacokinetic studies with huperzine A. It appears that huperzine A is rapidly absorbed from the gastrointestinal tract and transported to the liver via the portal circulation. Some first-pass metabolism takes place in the liver, and huperzine A and its metabolites are distributed widely in the body, including to the brain. Following ingestion, the time to reach peak blood level is approximately 80 minutes.

INDICATIONS AND USAGE

Huperzine A has potent pharmacological effects and, particularly since long-term safety has not been determined, it should only be used with medical supervision. It may have some effectiveness in Alzheimer's disease and age-related memory impairment. It has been used to treat fever and some inflammatory disorders, but there is no credible scientific evidence to support these uses.

RESEARCH SUMMARY

Numerous studies, most of them from China, suggest that huperzine A may be as effective as the drugs tacrine and donepezil in Alzheimer's disease. This is not so surprising since in vitro and animal model tests have demonstrated that huperzine A effectively inhibits acetylcholinesterase, an enzyme that catalyzes acetylcholine breakdown. Tacrine and donepezil work in the same way to conserve acetylcholine in the brain--the mode by which they presumptively improve memory and cognition in those with Alzheimer's and age-related cognitive impairment. Huperzine A may prove superior to tacrine (dose-limited due to its hepatotoxicity) if long-range studies, yet to be conducted, demonstrate its safety.

In one double-blind, randomized study, huperzine A, in injectable form, was tested against a saline control in 56 patients with multi-infarct dementia or senile dementia and in 104 patients with senile and pre-senile simple memory disorders. Huperzine A produced significant positive effects as measured by the Wechsler Memory Scale. Dizziness was experienced by a few of the huperzine A-treated patients.

In another study, this one multicenter, double-blind, placebo-controlled and randomized, 50 subjects with Alzheimer's disease were given huperzine A or placebo for eight weeks. Significant improvement was noted in 58 percent of the patients in terms of memory, cognitive and behavioral functions. Research is ongoing.

CONTRAINDICATIONS, PRECAUTIONS, ADVERSE REACTIONS CONTRAINDICATIONS

None known.

PRECAUTIONS

Huperzine A should be avoided by children, pregnant women and nursing mothers.

Because of possible adverse effects in those with seizure disorders, cardiac arrhythmias and asthma, those with these disorders should avoid huperzine A. Those with irritable bowel disease, inflammatory bowel disease and malabsorption syndromes should avoid huperzine A.

ADVERSE REACTIONS

Adverse effects reported with huperzine A include gastrointestinal effects, such as nausea and diarrhea, sweating, blurred vision, fasciculations and dizziness. Possible adverse effects include vomiting, cramping, bronchospasm, bradycardia, arrhythmias, seizures, urinary incontinence, increased urination and hypersalivation.

INTERACTIONS DRUGS

Acetylcholinesterase Inhibitors: Use of huperzine A along with the acetylcholinesterase inhibitors donepezil or tacrine may produce additive effects, including additive adverse effects. Other acetylcholinesterase inhibitors include neostigmine, physostigmine and pyridostigmine, and use of these agents along with huperzine A may produce additive effects, including additive adverse effects.

Cholinergic Drugs: Use of huperzine A along with cholinergic drugs, such as bethanechol, may produce additive effects, including additive adverse effects.

NUTRITIONAL SUPPLEMENTS

Use of huperzine A with choline, phosphatidylcholine, CDP-choline and L-alpha-glycerylphosphorylcholine hypothetically might produce additive effects, including additive adverse effects.

OVERDOSAGE

There are no reports of overdosage with huperzine A.

DOSAGE AND ADMINISTRATION

There are various forms of huperzine A available, including extracts of Huperzia serrata, natural (-)-huperzine A and synthetic racemic (±)-huperzine A. Natural (-)-huperzine A is approximately three times more potent than the synthetic racemic mixture. The doses of natural (-)-huperzine A used in clinical studies ranged from 60 micrograms to 200 micrograms daily. Huperzine A should only be used with a physician's recommendation and monitoring.

HOW SUPPLIED

Capsules — 50 mcg

Tablets — 50 mcg

LITERATURE

Cheng DH, Tang XC. Comparative studies of huperzine A, E-2020 and tacrine on behavior and cholinesterase activities. Pharmacol Biochem Behav. 1998; 60:377-386.

Cheng DH, Ren H, Tang XC. Huperzine A, a novel promising acetylcholinesterase inhibitor. Neuroreport. 1996; 8:97-101.

Quian BC, Wang M, Zhou ZF, et al. Pharmacokinetics of tablet huperzine A in six volunteers. Chung Kuo Yao Li Hsueh Pao. 1995; 16:396-398.

Tang XC, Kindel GH, Kozikowski AP, Hanin I. Comparison of the effects of natural and synthetic huperzine A on rat brain cholinergic function in vitro and in vivo. J Ethnopharmacol. 1994; 44:147-155.

Xiong ZQ, Tang XC. Effect of huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats. Pharmacol Biochem Behav. 1995; 51:415-419.

Xu SS, Gao ZX, Weng Z, et al. Efficacy of tablet huperzine-A on memory, cognition and behavior in Alzheimer's disease. Chung Kuo Yao Li Hsueh Pao. 1995; 16:391-395.

Ye JW, Cai JX, Wang LM, Tang XC. Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment. J Pharmacol Exp Ther. 1999; 288:814-819.

Zhang RW, Tang XC, Han YY, et al. Drug evaluation of huperzine A in the treatment of senile memory disorders. [Article in Chinese] Chung Kuo Yao Li Hsueh Pao. 1991; 12:250-252.

The CareGiver Blog

Robert T DeMarco

AllAmerican Senior Care

AllAmerican Senior Care Weblog

All American Investor: Treasury Inflation Protected Securities (TIPS)

2004-07-06T19:40:00.000-04:00

Treasury Inflation-Protected Securities, often called TIPS, are government issued securities whose value is linked to the inflation rate.
All American Investor: Treasury Inflation Protected Securities (TIPS):

Crimes Against Children on the Internet--What to do?

2004-06-27T19:53:00.000-04:00

The third in a series of articles on Internet Crimes Against Children.

Read the story at Watch Right Internet Crimes Against Children

All American Investor: YAHOO blocks Trillian--again

2004-06-24T14:02:00.000-04:00

All American Investor: YAHOO blocks Trillian--again

Test

2004-06-18T17:37:00.000-04:00

TesT